NATIONAL HEALTH INVESTORS INC
NHINYSE
$79.61
↑ +0.6%Jul 17 close · end-of-day
Price
1Y↑ +18.1%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
Market Cap
$3.9B
Enterprise Value
$3.8B
P/E
25.7
P/S
9.6
P/B
2.6
EV/EBITDA
—
PEG
1.0
FCF Yield
—
Dividend Yield
4.6%
Revenue (TTM)
$401.5M
Net Income (TTM)
$148.1M
Free Cash Flow (TTM)
—
Gross Margin
—
Operating Margin
—
Net Margin
36.9%
ROE
9.8%
ROIC
—
Debt / Equity
—
Net Cash
$24.9M
Return 1Y
+18.8%
Company profile
National Health Investors, Inc. (NYSE: NHI) is a real estate investment trust specializing in sale-leaseback, joint-venture, mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments.
- CEO
- D. Eric Mendelsohn
- Sector
- Finance, Insurance, And Real Estate
- Industry
- Trading
- Employees
- 20
- Headquarters
- Tennessee
- Website
- nhireit.com
Management & directors
- Mendelsohn D. EricCEO and President
- Spaid John LCFO/EVP Finance
- Travis David LSVP/Chief Accounting Officer
- Blankenship Elizabeth JacksonSVP, Legal Affairs
- Pascoe Kevin CarltonChief Investment Officer
- Gaines Kristin SalleeSVP/Chief Transaction Officer
Roles derived from SEC Form 4 filings.
Earnings
NHI Q1 2026 Earnings
Period ends 2026-03-31
MetricActualYoY
Revenue$115.1M↑ +28.9%
Diluted EPS$0.82↑ +10.8%
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
Financial statements
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $332.8M | $298.7M | $278.2M | $319.8M | $335.2M | $375.6M |
| Gross profit | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — |
| Net income | $185.1M | $111.8M | $66.4M | $135.7M | $138.0M | $142.2M |
| Diluted EPS | $4.14 | $2.44 | $1.48 | $3.13 | $3.13 | $3.02 |
| Operating cash flow | $232.1M | $210.9M | $185.3M | $184.4M | $207.8M | $236.6M |
| Free cash flow | $115.4M | $160.5M | $174.3M | $134.9M | $49.8M | -$57.5M |
| Gross margin | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — |
| Net margin | 55.6% | 37.4% | 23.9% | 42.4% | 41.2% | 37.9% |
| Line item | Q2 '24 | Q3 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $85.0M | $82.9M | $85.8M | $89.3M | $90.7M | $89.8M | $105.8M | $115.1M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — | — | — |
| Net income | $35.3M | $28.5M | $43.2M | $34.2M | $37.0M | $32.9M | $38.2M | $40.1M |
| Diluted EPS | $0.81 | $0.65 | $0.96 | $0.74 | $0.79 | $0.69 | $0.80 | $0.82 |
| Operating cash flow | $60.7M | $48.6M | $57.6M | $46.5M | $59.8M | $62.5M | $67.7M | $53.4M |
| Free cash flow | — | — | — | — | — | — | — | — |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | — | — | — | — | — | — | — | — |
| Net margin | 41.5% | 34.4% | 50.4% | 38.3% | 40.8% | 36.6% | 36.1% | 34.8% |
Company news
Jul 15, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
BoughtSoldMonthly insider $ volume · trailing 12 months
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-06-15 | MCCABE ROBERT A JR | Buy | 890 | $71.65 | $63,767.17 | filing |
| 2026-06-05 | Mendelsohn D. Eric· CEO and President | Buy | 1,500 | $68.84 | $103,260.00 | filing |
| 2026-06-05 | Jobe James R | Gift | 225 | $0.00 | $0.00 | filing |
| 2026-05-05 | Mendelsohn D. Eric· CEO and President | Tax withholding | 394 | $73.09 | $28,797.46 | filing |
| 2026-05-05 | Spaid John L· CFO/EVP Finance | Tax withholding | 314 | $73.09 | $22,950.26 | filing |
| 2026-05-05 | Travis David L· SVP/Chief Accounting Officer | Tax withholding | 282 | $73.09 | $20,611.38 | filing |
| 2026-03-03 | Spaid John L· CFO/EVP Finance | Tax withholding | 13,594 | $86.75 | $1.2M | filing |
| 2026-03-03 | Spaid John L· CFO/EVP Finance | Option exercise | 15,000 | $73.34 | $1.1M | filing |
| 2026-03-03 | Mendelsohn D. Eric· CEO and President | Tax withholding | 597 | $86.75 | $51,789.75 | filing |
| 2026-03-03 | Spaid John L· CFO/EVP Finance | Tax withholding | 511 | $86.75 | $44,329.25 | filing |
| 2026-03-03 | Spaid John L· CFO/EVP Finance | Tax withholding | 511 | $86.75 | $44,329.25 | filing |
| 2026-03-03 | Travis David L· SVP/Chief Accounting Officer | Tax withholding | 411 | $86.75 | $35,654.25 | filing |
| 2026-03-03 | Travis David L· SVP/Chief Accounting Officer | Award | 3,458 | $0.00 | $0.00 | filing |
| 2026-03-03 | Blankenship Elizabeth Jackson· SVP, Legal Affairs | Award | 2,420 | $0.00 | $0.00 | filing |
| 2026-03-03 | Blankenship Elizabeth Jackson· SVP, Legal Affairs | Award | 2,420 | $0.00 | $0.00 | filing |
| 2026-03-03 | PASCOE KEVIN CARLTON· Chief Investment Officer | Award | 4,726 | $0.00 | $0.00 | filing |
| 2026-03-03 | Spaid John L· CFO/EVP Finance | Award | 5,072 | $0.00 | $0.00 | filing |
| 2026-03-03 | Donohue Lilly | Award | 1,268 | $0.00 | $0.00 | filing |
| 2026-03-03 | COLDEN TRACY M J | Award | 1,268 | $0.00 | $0.00 | filing |
| 2026-03-03 | Todd Candice W | Award | 1,268 | $0.00 | $0.00 | filing |
| 2026-03-03 | Chapin Robert | Award | 1,268 | $0.00 | $0.00 | filing |
| 2026-03-03 | Jobe James R | Award | 1,268 | $0.00 | $0.00 | filing |
| 2026-03-03 | MCCABE ROBERT A JR | Award | 1,268 | $0.00 | $0.00 | filing |
| 2026-03-03 | Spaid John L· CFO/EVP Finance | Award | 4,726 | $0.00 | $0.00 | filing |
| 2026-03-03 | PASCOE KEVIN CARLTON· Chief Investment Officer | Award | 5,072 | $0.00 | $0.00 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.